Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB × NZWF[sub 1] mice

Hasegawa, K.; Hayashi, T.
November 2003
Lupus;2003, Vol. 12 Issue 11, p838
Academic Journal
The effect of synthetic CpG-oligodeoxynucleotides (CpG-ODN) on the development of lupus nephritis during preactive phase (within seven months of age) in autoimmune lupus NZB × NZWF[sub 1] (B/WF[sub 1]) mice was examined. Treatment of CpG-ODN was started at the age of 2.75 months and continued until 6.25 months. Overt disease began at the age of six months and progressed linearly at the age of 6.75 months in CpG-ODN-treated, but not control ODN-treated (control) groups. Also compared to control group, CpG-ODN-treated mice exhibited a severe glomerulonephritis (GN), with prominent deposits of IgG2a and C3, which paralleled increased titre of IgG2a type anti-nuclear antibody in the blood. Among several cytokines (interleukin, IL-6, IL-4, IL-1α, IL-10, interferon-γ and tumor necrosis factor-α) in blood, IL-6 production paralleled the development of lupus nephritis. The present study suggests that CpG-ODN may enhance IL-6 production. The role of IL-6 in the development of GN will be discussed.


Related Articles

  • Systemic lupus erythematosus and pregnancy: Today's scenario. Pandey, Deeksha; Pai, Murlidhar V.; Kumar, Pratap // Internet Journal of Gynecology & Obstetrics;2009, Vol. 11 Issue 2, p18 

    Systemic Lupus Erythematosus (SLE) is a rare disease, but the fact to be well appreciated is that 90% of the patients are females, that too of the reproductive age. Years ago, all medical texts said that lupus patients could not have children, and if they became pregnant, they should have...

  • Clinical and immunological profile of systemic lupus erythematosus. Pradhan, Vandana; Patwardhan, M.; Rajadhyaksha, A.; Ghosh, K. // Indian Pediatrics;Apr2013, Vol. 50 Issue 4, p405 

    Pediatric onset systemic lupus erythematosus (SLE) is not uncommon and female to male ratio varies. Pediatric SLE patients have more severe disease at onset, higher rates of organ involvement and more aggressive clinical course than adults. We compared the clinical and immunological parameters...

  • Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis. Zhongxin Jiang; Tao Sui; Bin Wang // Rheumatology International;Jul2010, Vol. 30 Issue 9, p1219 

    Recent evidence suggests that matrix metalloproteinases (MMPs) were involved with many kinds of kidney diseases. We investigated the roles of MMPs and its tissue inhibitors TIMPs in patients with lupus nephritis (LN). A total of 44 systemic lupus erythematosus patients and 31 healthy subjects...

  • The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus. Meng-Yu Weng; Chia-Tse Weng; Ming-Fei Liu // Clinical Rheumatology;Jul2010, Vol. 29 Issue 7, p771 

    Mycophenolate mofetil (MMF) has recently been introduced as an immunosuppressive agent for the treatment of glomerulonephritis with systemic lupus erythematosus (SLE) and the data have been encouraging. However, response to MMF treatment appears to differ ethnically. Therefore, we determined...

  • C1q complement component and -antibodies reflect SLE activity and kidney involvement. Horák, P.; Heřmanová, Z.; Zadražil, J.; Ciferská, H.; Ordeltová, M.; Kusá, L.; Žurek, M.; Tichý, T. // Clinical Rheumatology;Aug2006, Vol. 25 Issue 4, p532 

    The role of the complement system in the pathogenesis of systemic diseases is very ambivalent. In systemic lupus erythematosus (SLE), many abnormalities in the activation of the complement system have been reported. The most important antibodies formed against the complement system in SLE are...

  • Male gender results in more severe lupus nephritis. de Carvalho, Jozélio Freire; do Nascimento, Ana Patrícia; Testagrossa, Leonardo A.; Barros, Rui Toledo; Bonfá, Eloísa // Rheumatology International;Aug2010, Vol. 30 Issue 10, p1311 

    Gender may produce different characteristics in the manifestation of systemic lupus erythematosus (SLE). The present study investigated the influence of gender on clinical, laboratory, autoantibodies and histopathological classes of lupus nephritis (LN). As much as 81 patients diagnosed with SLE...

  • Anti-C1q autoantibodies, novel tests and clinical consequences. Mahler, Michael; van Schaarenburg, Rosanne A.; Trouw, Leendert A. // Frontiers in Immunology;Apr2013, preceding p1 

    Although anti-C1q autoantibodies have been described more than four decades ago a constant stream of papers describing clinical associations or functional consequences highlights that anti-C1q antibodies are still hot and happening. By far the largest set of studies focus on anti-C1q antibodies...

  • High-dose intravenous immunoglobulins for lupus nephritis—a salvage immunomodulation. Rauova, L.; Lukac, J.; Levy, Y.; Rovensky, J.; Shoenfeld, Y. // Lupus;Mar2001, Vol. 10 Issue 3, p209 

    Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease with a great diversity of clinical manifestations which is difficult to manage. IVIGs represent promising immuno-regulatory agents with the ability to control SLE without subsequent predisposition to infectious...


    An abstract of the article "Monoclonal Immune Deposits in Lupus Glomerulonephritis- A Case Report," is presented. The study aims to determine the pathogenic monoclonal autoimmune response in systemic lupus erythematosus. Information about the methods and analysis used in the research as well as...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics